MRSA infections in hospitals are a major issue in wound control. It’s an exciting idea. A recent article written up in Natures sister publication by Mark Blaskovitzch and colleagues at UQ shows early efficacy of anti-microbial synthetic CBD in killing staph without building resistance. Botanix pharmaceuticals (asx BOT) is about to commence a trial to see if this new antibiotic can eliminate bacterial blood infections in dialysis patients using synthetic CBD. If this tech is successful and preventing anti-biotic resistance you could see a synergy for BTM.
- Forums
- ASX - By Stock
- Ann: Webcast Recording - Investor Presentation and Update
MRSA infections in hospitals are a major issue in wound control....
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.47 |
Change
0.120(5.11%) |
Mkt cap ! $1.692B |
Open | High | Low | Value | Volume |
$2.38 | $2.52 | $2.38 | $4.066M | 1.650M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 19581 | $2.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.47 | 23481 | 31 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 19229 | 2.460 |
19 | 19259 | 2.450 |
14 | 29318 | 2.440 |
14 | 74327 | 2.430 |
8 | 10619 | 2.420 |
Price($) | Vol. | No. |
---|---|---|
2.470 | 23402 | 30 |
2.480 | 60319 | 25 |
2.490 | 76270 | 14 |
2.500 | 21959 | 13 |
2.510 | 212506 | 9 |
Last trade - 13.21pm 10/09/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |